ArticleOncology letters2015

Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine.

Mika Hosokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.